School of Medicine
Showing 811-820 of 922 Results
-
Linda C. Cork, DVM, PhD
Professor of Comparative Medicine, Emerita
Current Research and Scholarly InterestsDr. Linda Cork is Professor Emerita and former department chair. Her research focused on the identification and characterization of animal models of human neurodegenerative diseases. Dr. Cork no longer accepts students for mentoring.
-
Tyler Edward Cork
Postdoctoral Scholar, Radiological Sciences Laboratory
Current Research and Scholarly InterestsCurrently, I am involved in two main projects. The first is developing 3D printing techniques to improve the accuracy of ex vivo geometrical and microstructural cardiac modeling from in vivo cardiac MR acquisitions. The second is applying machine learning applications to MRI data as a way to improve overall image quality and reduce acquisition time.
-
Joanne Cornbleet
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsAs medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.
-
David N. Cornfield
Anne T. and Robert M. Bass Professor of Pediatric Pulmonary Medicine
Current Research and Scholarly InterestsOver the past 20 years, the Cornfield Laboratory has focused upon basic, translational and clinical research, with a primary focus on lung biology. As an active clinician-scientist, delivering care to acutely and chronically ill infants and children, our lab focuses on significant clinical challenges and tried to use science to craft novel solutions to difficult clinical problems.
-
Steven M. Corsello
Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur laboratory operates at the intersection of functional genomics and chemical biology, with the goal of advancing novel molecular mechanisms of cancer inhibition to clinical use. We aim to 1) leverage phenotypic screening and functional genomics to determine novel anti-cancer mechanisms of small molecules, 2) develop new targeted therapy approaches against solid tumors, and 3) build a comprehensive community resource for drug repurposing discovery.
